BlueBLOT-LINE Borrelia. Test Characteristics. Antibody Response

Similar documents
ELISA Range. VIROTECH Diagnostics GmbH. Lot independent. Reagent. System. IgG-Conjugate. Substrate. IgM-Conjugate. Washing Solution.

Fatigue, persistence after Lyme borreliosis 196, 197 Francisella tularensis, see Tularemia

1 of 12 23/11/ :25

LU:research Institutional Repository of Lund University

Q fever. Lyme disease LDA Conference Anja Garritsen 1. Lyme Disease Diagnostics. Today s presentation

Instructions for Use. Borrelia Veterinary plus OspA LINE

SUPPLEMENTARY INFORMATION. Microfluidics-based point-of-care test for serodiagnosis of Lyme Disease

Beyond the next generation: data mining and T cells. Amanda Semper, Scientific Programmes Manager, PHE Rare and Imported Pathogens Laboratory

Laboratory Diagnostics:

ENZYME IMMUNOASSAYS FOR THE DIAGNOSIS OF CHLAMYDIA INFECTIONS. Chlamydia sp. Chlamydia pneumoniae Chlamydia trachomatis INFECTIOUS SEROLOGY

Interpretation Criteria for Standardized Western Blots for Three European Species of Borrelia burgdorferi Sensu Lato

Chlamydia sp. Chlamydia pneumoniae Chlamydia trachomatis

STATEMENT FOR MANAGING LYME DISEASE IN NOVA SCOTIA

Peter J. Weina, PhD, MD, FACP, FIDSA. Colonel, Medical Corps, US Army Deputy Commander Walter Reed Army Institute of Research

Anti-Borrelia burgdorferi Antibody Profile in Post-Lyme Disease Syndrome

Technical Bulletin No. 121

VASCULITIS PRODUCT HIGHLIGHTS

ENZYME IMMUNOASSAYS AND AGGLUTINATION FOR THE DIAGNOSIS OF PERTUSSIS AND PARAPERTUSSIS

Borrelia B31 ViraChip IgG Test Kit

Infectious Diseases Expert Group (IDEG) Department of Health and Wellness. Statement for Managing Lyme Disease in Nova Scotia

Diagnosis of Lyme Borreliosis

Received 7 March 2002/Returned for modification 21 June 2002/Accepted 10 July 2002

Treponema Pallidum Total Antibody ELISA

Lyme Disease. Abstract Lyme disease is a vector borne infection primarily transmitted by Ixodes ticks and. Special Issue

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES

Lyme Disease. By Farrah Jangda

Treponema pallidum Total ELISA Kit

Lyme disease conference

A European Multicenter Study of Immunoblotting in Serodiagnosis of Lyme Borreliosis

Animal Health Diagnostic Center. Lyme Disease Multiplex Testing for Dogs. Background on Lyme disease and Lyme diagnostics in dogs

Treponema pallidum IgM ELISA Kit

Seroprevalence of Babesia microti in Individuals with Lyme Disease. Sabino R. Curcio, M.S, MLS(ASCP)

Received 22 November 2004/Returned for modification 14 January 2005/Accepted 17 April 2005

A Study of the Technique of Western Blot for Diagnosis of Lyme Disease caused by Borrelia afzelii in China *

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa

Detection of Multiple Reactive Protein Species by Immunoblotting after Recombinant Outer Surface Protein A Lyme Disease Vaccination

EBV-EA IgG. Cat # 1415Z. EBV -EA IgG ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate

Lyme Disease Diagnosis and Treatment

Tick Talk: What s new in Lyme Disease. May 5 th, 2017 Cristina Baker, M.D., M.P.H.

Received 23 November 1998/Returned for modification 8 March 1999/Accepted 6 April 1999

There is no Lyme Disease in Ireland?

HHS Public Access Author manuscript Nat Rev Dis Primers. Author manuscript; available in PMC 2017 August 02.

Health Council of the Netherlands. A closer look at Lyme disease. The Hague: Health Council of the Netherlands, 2013; publication no. 2013/12.

Diagnostic and Biological Significance of Anti-p41 IgM Antibodies against Borrelia burgdorferi

QUICK REFERENCE INSTRUCTIONS For use with Sofia and Sofia 2. Rx only

DIAGNOSTIC AUTOMATION, INC.

Explanation of the Lyme Disease Western Blot

Evaluation of two commercially available rapid diagnostic tests for Lyme borreliosis

Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses to Borrelia burgdorferi Years after Active Lyme Disease

Borrelia afzelii + VlsE IgG ELISA IgG Test Kit

by Vaccination with OspA

See external label 2 C-8 C Σ=96 tests Cat # EBV-VCA IgA. Cat # EBV -VCA IgA ELISA. ELISA: Enzyme Linked Immunosorbent Assay

: New graphic materials for bioelisa and bioblot product lines

Borrelia burgdorferi sensu lato complex Assay

Lyme borreliosis NATURE REVIEWS DISEASE PRIMERS VOLUME MacmilanPublishersLimited,partofSpringerNature.Alrightsreserved.

This kit is intended for Research Use Only. Not for use in diagnostic procedures.

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

PRICE LIST Effective Date: October 16, 2017

Mycoplasma pneumoniae IgG ELISA Kit

PCR in Laboratory Diagnosis of Human Borrelia burgdorferi Infections

Panel # Panel CPT Code Price 2010 AUTOIMMUNE PROFILE - BASIC 99.00

Design Verification. Form:

Laboratory diagnosis of Lyme borreliosis: Current state of the art and future perspectives

Cover Page. The handle holds various files of this Leiden University dissertation.

Humoral Immune Responses in Patients with Lyme Neuroborreliosis

Carnitine / Acylcarnitines Dried Blood Spots LC-MS/MS Analysis Kit User Manual

LIAISON Measles IgG The fully automated solution for quantitative antibody detection

Influenza A IgG ELISA

Lyme Disease Surveillance in Wisconsin Christopher Steward Division of Public Health Wisconsin Department of Health Services 04/10/2014

Lyme Neuroborreliosis

Viramed Biotech AG Borrelia B31 IgG ViraStripe

LYME DISEASE Last revised May 30, 2012

Herpes Simplex Virus 2 IgM HSV 2 IgM

Department of Medical Microbiology, University Hospital Maastricht, Maastricht, The Netherlands

Chlamydia Trachomatis IgG ELISA Kit

Anti-Borrelia burgdorferi antibody profile in post-lyme disease syndrome

QUICK REFERENCE INSTRUCTIONS

False-negative serology in patients with neuroborreliosis and the value of employing of different borrelial strains in serological assays

Chlamydia Trachomatis IgM ELISA Kit

Lyme Arthritis: Current Concepts and a Change in Paradigm ACCEPTED. Madison, Wisconsin, and Microbiology Research Laboratory and Section of Infectious

CDIA TM Rubella IgG/IgM Rapid Test Kit

Panel & Test Price List Effective Date: October 16, 2017

Sofia Lyme FIA. For use with Sofia Analyzer only CLIA Complexity: Moderate for serum and plasma specimens

PE1662/E Lyme Disease Action submission of 27 October 2017

Borrelia afzelii IgM ELISA IgM Test Kit

ELISA-VIDITEST anti-mycoplasma pneumoniae IgG assay Lot:

CHEMILUMINESCENCE ENZYME IMMUNOASSAY (CLIA) Toxoplasma IgG. Cat # (20-25 C Room temp.) Volume

Update on Lyme Disease Surveillance in Wisconsin for Providers and Laboratories

FinTest IgG4 Screen 20 ELISA KIT

H. pylori IgM CLIA kit

MATERIALS AND COMPONENTS ASSAY PROCEDURE MATERIALS REQUIRED BUT NOT PROVIDED RESULTS

CyBio Felix Your Automated Application Starts Here

Toxoplasma gondii IgM (Toxo IgM)

The PATH to better cardiac care starts here

Human HBcAb IgM ELISA kit

Prospective Study of Serologic Tests for Lyme Disease

Transcription:

BlueDiver Instrument IMMUNOBLOT KITS FOR DIAGNOSIS OF LYME BORRELIOSIS INFECTIOUS SEROLOGY IN NEW AUTOMATED SYSTEM FOR THE ANALYSIS AND EVALUATION OF IMMUNOBLOTS BlueDiver Instrument, Immunoblot Software and BlueBLOT-LINE Borrelia kits - a comprihensive solution for simple, fast and accurate analysis of immunoblots including evaluation

BlueBLOT-LINE Borrelia Immunoblot kits are optimized and validated for detection of IgG and IgM antibodies to recombinant antigens of Borrelia species and Anaplasma phagocytophila (HGA) in human serum and plasma. Lyme borreliosis (LB) is a multisystem infectious disease caused by spirochete Borrelia burgdorferi. The infection is transmitted by ticks of the genus Ixodes. Lyme borreliosis is characterized by early and late clinical symptoms: Early localised infection lasts days to weeks. The specific clinical sign of this phase is erythema migrans (EM), which appears in only 50% of patients. Early symptoms of the disease include flu-like symptoms, headaches and lymphadenitis. Early disseminated infection lasts weeks to months. Borrelia bacteria are disseminated by blood and lymphatic system (CNS, joints, heart, eye and skin secondary EM). In this phase, neuroborreliosis, neurofacialis paresis, borrelial lymphocytoma (swollen earlobes, knucklebones, etc.) and Bannwarth syndrome are the most frequently diagnosed symptoms. Late disseminated infection lasts months to years. Immunopathological changes occur. The typical diagnostic findings are acrodermatitis chronica atrophicans (chronic skin lesions ACA), chronic neuroborreliosis and borrelial arthritis. Human granulocytic anaplasmosis (HGA) is a disease caused by Anaplasma phagocytophila bacteria. Clinically, the disease can manifest itself in various ways from entirely asymptomatic to rather serious forms. Antibody Response Test Characteristics 9 8 7 IgM IgG IMMUNOBLOT Diagnostic sensitivity Diagnostic specificity IP* 6 5 4 BlueBLOT-LINE Borrelia IgG 98.20% 99.00% 3 2 1 BlueBLOT-LINE Borrelia IgM 98.40% 99.00% 0 0 1 2 3 4 5 6 Month Immunoblot IgM IgG

Antigens Summary BlueBLOT-LINE Borrelia IgG Diagnostic importance VLSE Ba VLSE Bs p58 p41 p39 OspB OspA Ba OspA Bg OspA Bs OspC p17 NapA Variable major protein-like sequence, expressed; Species specific antigen Main antigen of early and late antibody response to LB Significantly increases test sensitivity (approx. 90% of samples of positive sera and CSF react in this antigen band) Main extracellular protein (product of p100 degradation) Late antibody response antigen Highly immunoreactive antigen, typical of neuroborreliosis OppA-2 (Oligopeptide permease 2) - membrane transporter Considered a marker of disseminated stage of Lyme disease Inner part of flagellin Highly specific antigen of early antibody response BmpA (glycosaminopeptide receptor) Antigen of late antibody response Significant antigen for advanced disseminated form of LB, often associated with Lyme arthritis Outer surface protein B Antigen of late antibody response Outer surface protein A Antigen of late antibody response, typical of neuroborreliosis Outer surface protein C Antigen of early antibody response DbpA (Decorin-Binding protein A) Antigen of early and late antibody response, typical of neuroborreliosis Neutrophil activating protein A Strong immunogen, main marker of Lyme arthritis pathogenesis TA 1 Reactive control IgG Conjugate control VLSE Bs VLSE Ba p58 p41 Bs p39 Ba OspB OspA Ba OspA Bg OspA Bs OspC Bg p17 Bg NapA Bs TpN17 BlueBLOT-LINE Borrelia IgG TpN17 Main antigen of antibody response to HGA Outer membrane protein A of Anaplasma phagocytophilum, peptidoglycan-associated lipoprotein, significant virulence marker Highly specific membrane protein of Treponema pallidum The test is based on highly specific recombinant Borrelia antigens. Nevertheless, it is sometimes possible to observe cross reactivity with other pathogens which can result in false positive results. The IgM test uses a highly specific and sensitive EBV marker (VCA-p18) to eliminate false positive Borrelia results, the IgG test uses the antigen TnN17 which is an important marker of syphilis infection.

BlueBLOT-LINE Borrelia IgM Diagnostic importance p41 p39 OspC Ba OspC Bg OspC Bs OspC Bsp p17 p18 Variable major protein-like sequence, expressed; Species specific antigen Main antigen of early and late antibody response to LB Significantly increases test sensitivity (approx. 90% of samples of positive sera and CSF react in this antigen band) Main extracellular protein (product of p100 degradation) Late antibody response antigen Highly immunoreactive antigen, typical of neuroborreliosis Inner part of flagellin Highly specific antigen of early antibody response BmpA (glycosaminopeptide receptor) Antigen of late antibody response Significant antigen for advanced disseminated form of LB, often associated with Lyme arthritis Outer surface protein C Antigen of early antibody response DbpA (Decorin-Binding protein A) Antigen of early and late antibody response, typical of neuroborreliosis Main antigen of antibody response to HGA Outer membrane protein A of Anaplasma phagocytophilum, peptidoglycan-associated lipoprotein, significant virulence marker Viral Capsid Antigen p18 Important marker of EBV infection TB 1 Reactive control IgM Conjugate control p41 Bs p39 Ba OspC Bs OspC Ba OspC Bsp OspC Bg p17 Bg EBV p18 BlueBLOT-LINE Borrelia IgM Protocol Summary Inserting holders with strips and reagents into the instrument Automatic batch and expiry control using the integrated barcode reader Samples pipetting Automated incubation and ing Strips drying Total assay time: 0:00 incubation with sample 30 min 1 min 3 x 2 min conjugate 20 min 3 x 2 min substrate 10 min 2 min 1:14

BlueDiver Instrument Simple, smart and small sized device for complete automation of the immunodot method. Parameters Dimensions: 51.5 x 29.8 x 28.9 cm (W x H x D) Weight: 16 kg Controlling: touchscreen Sample capacity: 1 24 Input voltage: 24 V Power: 40 W Communication interface: USB 2.0 connector type A use only with USB flash drive Closed system - preprogramed analysis protocol. Integrated barcode and 2D code reader. Unique Features and Advantages Space-saving small sized and compact instrument without a need for extra devices No risk of contamination no pumps, inlet hoses, handling with liquid reagents, dead volumes; disposable cartridges are ready to use High flexibility it is possible to analyze up to 24 various strips at the same time - compatibility of the whole product range of D-tek and TestLine intended for automation Easy to use and short hands on time simply insert the test strips, disposable reagent cartridges, patient samples and then follow the instructions on the touchscreen High reliability compatibility of strips and reagents automatically checked using the integrated barcode reader Extremely short analysis time through innovative patented process

Immunoblot Software Scanning device in combination with user friendly and intuitive evaluation software. Ordering Information Cat. No. Product No. of Tests BD-BGL024 BlueBLOT-LINE Borrelia IgG 24 BD-BML024 BlueBLOT-LINE Borrelia IgM 24 Distributor TestLine Clinical Diagnostics s.r.o. Křižíkova 68, 612 00 Brno Phone: +420 549 121 259, Fax: +420 541 243 390 info@testlinecd.com, www.testlinecd.com